Staffing & Employment Services
Compare Stocks
2 / 10Stock Comparison
MAN vs TBI
Revenue, margins, valuation, and 5-year total return — side by side.
Staffing & Employment Services
MAN vs TBI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Staffing & Employment Services | Staffing & Employment Services |
| Market Cap | $1.41B | $182M |
| Revenue (TTM) | $17.96B | $1.25B |
| Net Income (TTM) | $-13M | $-53M |
| Gross Margin | 16.7% | 28.4% |
| Operating Margin | 0.8% | -2.6% |
| Forward P/E | 8.3x | — |
| Total Debt | $2.39B | $171M |
| Cash & Equiv. | $871M | $25M |
MAN vs TBI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ManpowerGroup Inc. (MAN) | 100 | 44.0 | -56.0% |
| TrueBlue, Inc. (TBI) | 100 | 38.9 | -61.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MAN vs TBI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MAN carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 1.03, yield 4.7%
- -30.8% 10Y total return vs TBI's -68.4%
- Lower volatility, beta 1.03, current ratio 1.11x
TBI is the clearest fit if your priority is growth exposure.
- Rev growth 3.1%, EPS growth 61.4%, 3Y rev CAGR -10.5%
- 3.1% revenue growth vs MAN's 0.6%
- +51.0% vs MAN's -17.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.1% revenue growth vs MAN's 0.6% | |
| Quality / Margins | -0.1% margin vs TBI's -4.3% | |
| Stability / Safety | Beta 1.03 vs TBI's 1.13 | |
| Dividends | 4.7% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +51.0% vs MAN's -17.0% | |
| Efficiency (ROA) | -0.1% ROA vs TBI's -8.1%, ROIC 5.6% vs -5.2% |
MAN vs TBI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MAN vs TBI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
MAN leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MAN is the larger business by revenue, generating $18.0B annually — 14.4x TBI's $1.2B. Profitability is closely matched — net margins range from -0.1% (MAN) to -4.3% (TBI). On growth, MAN holds the edge at +7.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $18.0B | $1.2B |
| EBITDAEarnings before interest/tax | $236M | -$10M |
| Net IncomeAfter-tax profit | -$13M | -$53M |
| Free Cash FlowCash after capex | -$161M | -$60M |
| Gross MarginGross profit ÷ Revenue | +16.7% | +28.4% |
| Operating MarginEBIT ÷ Revenue | +0.8% | -2.6% |
| Net MarginNet income ÷ Revenue | -0.1% | -4.3% |
| FCF MarginFCF ÷ Revenue | -0.9% | -4.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.1% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +36.2% | -37.5% |
Valuation Metrics
MAN leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, MAN's 9.0x EV/EBITDA is more attractive than TBI's 160.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.4B | $182M |
| Enterprise ValueMkt cap + debt − cash | $2.9B | $329M |
| Trailing P/EPrice ÷ TTM EPS | -104.90x | -3.73x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.28x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 9.02x | 160.03x |
| Price / SalesMarket cap ÷ Revenue | 0.08x | 0.11x |
| Price / BookPrice ÷ Book value/share | 0.69x | 0.65x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
MAN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MAN delivers a -0.6% return on equity — every $100 of shareholder capital generates $-1 in annual profit, vs $-19 for TBI. TBI carries lower financial leverage with a 0.62x debt-to-equity ratio, signaling a more conservative balance sheet compared to MAN's 1.16x. On the Piotroski fundamental quality scale (0–9), TBI scores 4/9 vs MAN's 1/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -0.6% | -18.7% |
| ROA (TTM)Return on assets | -0.1% | -8.1% |
| ROICReturn on invested capital | +5.6% | -5.2% |
| ROCEReturn on capital employed | +6.2% | -5.3% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 4 |
| Debt / EquityFinancial leverage | 1.16x | 0.62x |
| Net DebtTotal debt minus cash | $1.5B | $146M |
| Cash & Equiv.Liquid assets | $871M | $25M |
| Total DebtShort + long-term debt | $2.4B | $171M |
| Interest CoverageEBIT ÷ Interest expense | 1.98x | -46.19x |
Total Returns (Dividends Reinvested)
MAN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MAN five years ago would be worth $3,514 today (with dividends reinvested), compared to $2,130 for TBI. Over the past 12 months, TBI leads with a +51.0% total return vs MAN's -17.0%. The 3-year compound annual growth rate (CAGR) favors MAN at -18.8% vs TBI's -26.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +1.2% | +36.6% |
| 1-Year ReturnPast 12 months | -17.0% | +51.0% |
| 3-Year ReturnCumulative with dividends | -46.4% | -60.2% |
| 5-Year ReturnCumulative with dividends | -64.9% | -78.7% |
| 10-Year ReturnCumulative with dividends | -30.8% | -68.4% |
| CAGR (3Y)Annualised 3-year return | -18.8% | -26.4% |
Risk & Volatility
Evenly matched — MAN and TBI each lead in 1 of 2 comparable metrics.
Risk & Volatility
MAN is the less volatile stock with a 1.03 beta — it tends to amplify market swings less than TBI's 1.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TBI currently trades 77.2% from its 52-week high vs MAN's 64.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.03x | 1.13x |
| 52-Week HighHighest price in past year | $47.34 | $7.78 |
| 52-Week LowLowest price in past year | $25.15 | $3.18 |
| % of 52W HighCurrent price vs 52-week peak | +64.3% | +77.2% |
| RSI (14)Momentum oscillator 0–100 | 47.1 | 83.2 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 386K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates MAN as "Hold" and TBI as "Buy". Consensus price targets imply 24.5% upside for MAN (target: $38) vs -4.3% for TBI (target: $6). MAN is the only dividend payer here at 4.71% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $37.86 | $5.75 |
| # AnalystsCovering analysts | 29 | 10 |
| Dividend YieldAnnual dividend ÷ price | +4.7% | — |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | $1.43 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.7% | +0.6% |
MAN leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.
MAN vs TBI: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is MAN or TBI a better buy right now?
For growth investors, TrueBlue, Inc.
(TBI) is the stronger pick with 3. 1% revenue growth year-over-year, versus 0. 6% for ManpowerGroup Inc. (MAN). Analysts rate TrueBlue, Inc. (TBI) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — MAN or TBI?
Over the past 5 years, ManpowerGroup Inc.
(MAN) delivered a total return of -64. 9%, compared to -78. 7% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: MAN returned -30. 8% versus TBI's -68. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — MAN or TBI?
By beta (market sensitivity over 5 years), ManpowerGroup Inc.
(MAN) is the lower-risk stock at 1. 03β versus TrueBlue, Inc. 's 1. 13β — meaning TBI is approximately 10% more volatile than MAN relative to the S&P 500. On balance sheet safety, TrueBlue, Inc. (TBI) carries a lower debt/equity ratio of 62% versus 116% for ManpowerGroup Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — MAN or TBI?
By revenue growth (latest reported year), TrueBlue, Inc.
(TBI) is pulling ahead at 3. 1% versus 0. 6% for ManpowerGroup Inc. (MAN). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to -109. 6% for ManpowerGroup Inc.. Over a 3-year CAGR, MAN leads at -3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — MAN or TBI?
ManpowerGroup Inc.
(MAN) is the more profitable company, earning -0. 1% net margin versus -3. 0% for TrueBlue, Inc. — meaning it keeps -0. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MAN leads at 1. 3% versus -1. 7% for TBI. At the gross margin level — before operating expenses — TBI leads at 21. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is MAN or TBI more undervalued right now?
Analyst consensus price targets imply the most upside for MAN: 24.
5% to $37. 86.
07Which pays a better dividend — MAN or TBI?
In this comparison, MAN (4.
7% yield) pays a dividend. TBI does not pay a meaningful dividend and should not be held primarily for income.
08Is MAN or TBI better for a retirement portfolio?
For long-horizon retirement investors, ManpowerGroup Inc.
(MAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 03), 4. 7% yield). Both have compounded well over 10 years (MAN: -30. 8%, TBI: -68. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between MAN and TBI?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MAN is a small-cap income-oriented stock; TBI is a small-cap quality compounder stock. MAN pays a dividend while TBI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.